Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Health Science Reports|January 13, 2022
Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infectionAkio Miyasaka, Yuichi Yoshida, Akihiko Murakami, et al.
DEN Open|August 28, 2025
Successful Colonic Stenting Across the Ileocecal Valve With Severe Malignant Stenosis Using Ultra-thin Scope and Single-balloon OvertubeTakato Maeda, Norihiro Hanabata, Shohei Igarashi, et al.
Case Reports in Gastroenterology|July 2, 2026
Sequential Pancreatic Ascites and Hemosuccus Pancreaticus from an Identical Rupture Site in Branch-Duct Intraductal Papillary Mucinous Neoplasm: A Case ReportSeiya Sasakura, Masayoshi Ko, Takato Maeda, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
The utility of two-dimensional real-time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis C virus infectionHiroshi Numao, Koji Shimaya, Akihisa Kakuta, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 9, 2025
[Hepatocellular carcinoma developing autoimmune hemolytic anemia after atezolizumab and bevacizumab combination therapy, transitioning to second-line treatment following improvement:a case report]Masayoshi Ko, Kota Fujimaki, Shohei Igarashi, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 14, 2023
[Gastric varices treated by balloon-occluded retrograde transvenous obliteration following oxaliplatin-based chemotherapy for gastric cancer]Shohei Igarashi, Masaki Munakata, Sho Suto, et al.
Clinical Journal of Gastroenterology|April 25, 2025
Relapsed refractory immune checkpoint inhibitor-induced colitis treated with tacrolimus and maintained with vedolizumabShohei Igarashi, Koji Shimaya, Kota Fujimaki, et al.
DEN Open|September 4, 2023
Morphological change of foveolar-type gastric adenocarcinoma after proton pump inhibitor discontinuation in a short time period: A case reportShohei Igarashi, Norihiro Hanabata, Keisuke Furusawa, et al.
Scientific Reports|April 21, 2022
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, JapanMasashi Fujita, Kazumichi Abe, Hidekatsu Kuroda, et al.
Liver Cancer|August 18, 2022
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential TherapyHidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, et al.
Pageof 2